INDV vs LLY: stock comparison and AI forecast
Indivior Pharmaceuticals, Inc. (INDV) and Eli Lilly & Co (LLY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
INDV Indivior Pharmaceuticals, Inc.
- Price
- $35.37 -3.8% · 6M
- Market Cap
- $4.17B
- P/E Ratio
- 8.6x
- Size
- mid-cap
- AI Forecast
- NO CURRENT FORECAST
LLY Eli Lilly & Co
- Price
- $1364.73 +40.0% · 6M
- Market Cap
- $1.28T
- P/E Ratio
- 44.3x
- Size
- mega-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- LLY is 307.6 times larger than INDV by market capitalization ($1.28T against $4.17B).
- INDV trades at 8.6 times trailing earnings, LLY at 44.3 times.
- Over the last six months LLY returned +40.0% and INDV -3.8%.
- LLY yields 0.47% in dividends; INDV pays none.
- Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | INDV | LLY |
|---|---|---|
| Market Cap | $4.17B | $1.28T |
| P/E Ratio | 8.63x | 44.29x |
| P/B Ratio | – | 130.62x |
| Dividend Yield | – | 0.47% |
| EPS | $4.10 | $30.81 |
| Book Value/Share | – | $10.45 |
| Revenue/Share | $11.63 | $91.91 |
| FCF/Share | $0.26 | – |
Profitability & Margins
| Metric | INDV | LLY |
|---|---|---|
| Gross Margin | 84.8% | 83.6% |
| Operating Margin | 41.0% | – |
| Net Margin | 32.1% | – |
| EBT Margin | 39.6% | 135.0% |
| Tax Rate | 16.5% | 20.7% |
Financial Health
| Metric | INDV | LLY |
|---|---|---|
| Current Ratio | 0.61x | 1.39x |
| Quick Ratio | 0.50x | 1.00x |
| D/E Ratio | – | 3.36x |
| Interest Coverage | 6.8x | – |
| Working Capital | -$501M | $18.27B |
Cash Flow
| Metric | INDV | LLY |
|---|---|---|
| Operating Cash Flow | $96M | $30.64B |
| Free Cash Flow | $31M | – |
| Capital Spending | -$65M | – |
| OCF Growth YoY | -52.7% | 90.8% |
| FCF Growth YoY | -79.8% | – |
| FCF/Sales | 2.3% | – |
| CapEx/Sales | 4.7% | – |
Operational Efficiency
| Metric | INDV | LLY |
|---|---|---|
| Receivables Turnover | 5.0x | 3.9x |
| Inventory Turnover | 1.4x | 0.8x |
| Fixed Assets Turnover | 7.8x | 2.7x |
| Days Sales Outstanding | 73 days | 93 days |
| Days Inventory | 261 days | 469 days |
| Payables Period | 49 days | 149 days |
| Cash Conversion Cycle | 285 days | 413 days |
Income Statement
| Metric | INDV | LLY |
|---|---|---|
| Total Revenue | $1.37B | $86.46B |
| Operating Income | $558M | – |
| Net Income | $436M | – |
| R&D Expense | $54M | $15.38B |
| SG&A Expense | $553M | $12.62B |
| Cost of Goods Sold | $208M | $14.15B |
Dividend & Shareholder Information
| Metric | INDV | LLY |
|---|---|---|
| Dividends Per Share | – | $6.36 |
| Payout Ratio | – | 20.6% |
| Shares Outstanding | 118M | 941M |
| Net Income Growth | 305.6% | – |
| EPS Growth | 1123.9% | 50.7% |
INDV vs LLY: stock comparison and AI forecast
Which is bigger, INDV or LLY?
LLY is 307.6 times larger than INDV by market capitalization ($1.28T against $4.17B).
Which is cheaper on earnings, INDV or LLY?
INDV trades at 8.6 times trailing earnings, LLY at 44.3 times.
Which stock performed better over the last six months, INDV or LLY?
Over the last six months LLY returned +40.0% and INDV -3.8%.
Which one does Intratio's AI model rank higher, INDV or LLY?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.